Newsroom Stories

Research from Ryan Bogdan’s BRAIN Lab in Arts & Sciences finds signs of psychopathology persist into mid-adolescence in kids exposed to cannabis in the womb.

While water pressure has been restored in Jackson, Miss., the water is still not safe to drink and a boil order remains in effect. The ongoing issues are a result of years of neglect and of environmental racism, says Tara Rocque at the School of Law.

Chancellor Andrew D. Martin and Provost Beverly Wendland have appointed a 13-member committee to identify candidates for the position of dean of the Brown School.

Staggeringly disproportionate startup funding available to founders who are women or underrepresented minorities has inspired the next project of the Olin Brookings Commission.

Weedy rice is a closely related cousin of crop rice that aggressively competes with cultivated rice in the field. Scientists from Washington University and the University of Arkansas report that the crop pest has become widely herbicide resistant. The study highlights challenges facing U.S. rice farmers when they battle a weedy enemy that is closely related to a desirable crop plant.

In “FIELD-STATION,” a new mural for the Sam Fox School of Design & Visual Arts, Houston-based architectural practice HOME-OFFICE explores the confluence of forestry, activism and place-based research.

The world’s first nasal vaccine for COVID-19 was approved Sept. 6 in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University and developed in collaboration with Bharat Biotech International Limited in India.

Men with low testosterone who develop COVID-19 are at elevated risk of becoming seriously ill and ending up in the hospital, according to a study by researchers at Washington University School of Medicine and Saint Louis University School of Medicine.

Senior Amanda Sherman is back to ambush — ahem, interview — Washington University in St. Louis students (and a WashU canine) about the new academic year.

A new study from Washington University School of Medicine suggests a simple blood test — administered before CAR-T cell treatment is initiated — may identify which patients are predisposed to developing neurotoxic side effects after CAR-T cell therapy, which is used to treat several cancers.